BioMarin Pharmaceutical
BMRN
#2053
Rank
โ‚ฌ8.39 B
Marketcap
43,44ย โ‚ฌ
Share price
1.57%
Change (1 day)
-17.87%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): โ‚ฌ0.32 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚ฌ3.24 Billion. In 2025 the company made an earning of โ‚ฌ0.41 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.32 B-20.76%
2025 โ‚ฌ0.41 B-10.94%
2024 โ‚ฌ0.46 B187.31%
2023 โ‚ฌ0.16 B26.07%
2022 โ‚ฌ0.12 B-298.51%
2021 -โ‚ฌ64.88 Million78.04%
2020 -โ‚ฌ36.44 Million-55.36%
2019 -โ‚ฌ81.64 Million-33.56%
2018 -โ‚ฌ0.13 Billion297.78%
2017 -โ‚ฌ30.89 Million-95.68%
2016 -โ‚ฌ0.72 Billion437.12%
2015 -โ‚ฌ0.14 Billion23.91%
2014 -โ‚ฌ0.11 Billion-29.25%
2013 -โ‚ฌ0.16 Billion49.23%
2012 -โ‚ฌ0.11 Billion171.11%
2011 -โ‚ฌ37.57 Million103.01%
2010 -โ‚ฌ18.51 Million-3903.54%
2009 โ‚ฌ0.48 M-98.31%
2008 โ‚ฌ28.77 M-189.7%
2007 -โ‚ฌ32.09 Million51.02%
2006 -โ‚ฌ21.25 Million-61.58%
2005 -โ‚ฌ55.29 Million-56.59%
2004 -โ‚ฌ0.13 Billion95.13%
2003 -โ‚ฌ65.27 Million12.09%
2002 -โ‚ฌ58.23 Million73.19%
2001 -โ‚ฌ33.62 Million18.32%
2000 -โ‚ฌ28.42 Million19.65%
1999 -โ‚ฌ23.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ6.59 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.47 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93.88 Million-128.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.63 Million-107.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.16 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.24 B-26.47%๐Ÿ‡บ๐Ÿ‡ธ USA